
Empire Limited
EMLAF | OTC
$35.29
$0.00 (0.00%)
Nov 2, 2026, 12:20 PM ET · Market open
TTM Period Ending | Q1 2027 Jul 31, 2026 | Q4 2026 Apr 30, 2026 | Q3 2026 Jan 31, 2026 | Q2 2026 Oct 31, 2025 | Q1 2026 Aug 2, 2025 | Q4 2025 Apr 30, 2025 | Q3 2025 Jan 31, 2025 | Q2 2025 Oct 31, 2024 | Q1 2025 Jul 31, 2024 | Q4 2024 Apr 30, 2024 | Q3 2024 Jan 31, 2024 | Q2 2024 Oct 31, 2023 | Q1 2024 Jul 31, 2023 | Q4 2023 May 6, 2023 | Q3 2023 Feb 4, 2023 | Q2 2023 Nov 5, 2022 | Q1 2023 Jul 31, 2022 | Q4 2022 Apr 30, 2022 | Q3 2022 Jan 31, 2022 | Q2 2022 Oct 31, 2021 | Q1 2022 Jul 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 32.17B | 31.97B | 31.82B | 31.66B | 31.48B | 31.36B | 31.12B | 30.89B | 30.87B | 30.8B | 30.82B | 30.82B | 30.72B | 30.58B | 31.01B | 30.92B | 30.58B | 30.27B | 29.36B | 28.97B | 28.62B |
Cost of Revenue | 23.77B | 23.29B | 23.16B | 23.04B | 22.91B | 22.9B | 22.77B | 22.64B | 22.67B | 22.66B | 22.71B | 22.79B | 22.73B | 22.69B | 23.07B | 22.97B | 22.75B | 22.5B | 21.79B | 21.52B | 21.28B |
Gross Profit | 8.4B | 8.69B | 8.66B | 8.62B | 8.57B | 8.46B | 8.35B | 8.26B | 8.2B | 8.14B | 8.11B | 8.03B | 7.99B | 7.9B | 7.93B | 7.95B | 7.83B | 7.77B | 7.57B | 7.45B | 7.34B |
Operating Income | 1.27B | 1.25B | 1.27B | 1.28B | 1.3B | 1.29B | 1.27B | 1.23B | 1.22B | 1.31B | 1.34B | 1.32B | 1.34B | 1.23B | 1.24B | 1.37B | 1.36B | 1.36B | 1.33B | 1.29B | 1.27B |
Interest Income | 36M | 36M | 36.5M | 36.4M | 29.2M | 26.1M | 26M | 27M | 26.1M | 27.1M | 25.7M | 24M | 21.3M | 21.7M | 23.2M | 23.7M | 26.4M | 26.4M | 25.8M | 25.7M | 28M |
Pretax Income | 334M | 308M | 271.6M | 995.5M | 1.01B | 995M | 975M | 940.1M | 937.9M | 1.03B | 1.06B | 1.05B | 1.07B | 965.4M | 965.6M | 1.09B | 1.08B | 1.08B | 1.06B | 1.02B | 1B |
Net Income | 219M | 198M | 158.7M | 689.8M | 704.2M | 700M | 676.2M | 664.3M | 672M | 725.2M | 759.2M | 750.7M | 759.5M | 686M | 681.6M | 759.3M | 744.8M | 745.8M | 739.2M | 712.1M | 698.1M |
Selling & General & Admin | 7.15B | 7.46B | 7.39B | 7.35B | 7.28B | 7.21B | 7.17B | 7.12B | 7.07B | 7B | 6.94B | 6.87B | 6.79B | 6.7B | 6.74B | 6.66B | 6.55B | 6.49B | 6.29B | 6.19B | 6.1B |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | -18M | -32M | -2.2M | -4.5M | -3.3M | -29M | -86.9M | -91.1M | -99.6M | -171M | -168.2M | -167.3M | -148.5M | -39.6M | -51M | -74.5M | -71.8M | -85.3M | -50.8M | -24.6M | -25.9M |
Operating Expenses | 7.13B | 7.43B | 7.39B | 7.35B | 7.27B | 7.18B | 7.08B | 7.03B | 6.97B | 6.83B | 6.77B | 6.71B | 6.64B | 6.66B | 6.69B | 6.59B | 6.47B | 6.41B | 6.24B | 6.16B | 6.07B |
Interest Expense | 318M | 317M | 318.4M | 319.8M | 321.5M | 321M | 319.2M | 315.4M | 309.2M | 304.3M | 298.4M | 295.7M | 290.2M | 285M | 298.4M | 296.6M | 298.8M | 301.9M | 285.4M | 285.4M | 287.3M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 30.9B | 30.72B | 30.55B | 30.39B | 30.18B | 30.07B | 29.85B | 29.66B | 29.64B | 29.49B | 29.48B | 29.49B | 29.37B | 29.35B | 29.76B | 29.55B | 29.22B | 28.91B | 28.03B | 27.68B | 27.35B |
Income Tax Expense | 69M | 62M | 68.6M | 260M | 262.2M | 249M | 251M | 236.1M | 227.1M | 266M | 267.9M | 258.6M | 272.6M | 237.7M | 232.4M | 273.3M | 273.4M | 270.3M | 257.1M | 249.2M | 244.5M |
Shares Outstanding (Basic) | 224.57M | 228.84M | 228.84M | 230.79M | 232.97M | 233.9M | 236.4M | 238.53M | 241.95M | 247.13M | 246.29M | 249.32M | 251.73M | 255.4M | 257.91M | 260.14M | 262.18M | 263.71M | 264.09M | 265.37M | 266.98M |
Shares Outstanding (Diluted) | 224.9M | 229.33M | 229.33M | 231.44M | 233.41M | 234.8M | 237.2M | 239.18M | 242.29M | 247.63M | 246.81M | 249.86M | 252.21M | 255.4M | 258.41M | 260.61M | 262.98M | 264.83M | 264.9M | 266.26M | 268.11M |
EPS (Basic) | 0.98 | 0.85 | 0.66 | 2.96 | 3 | 2.95 | 2.81 | 2.73 | 2.73 | 2.91 | 3.03 | 2.98 | 2.98 | 2.66 | 2.61 | 2.89 | 2.82 | 2.81 | 2.78 | 2.67 | 2.61 |
EPS (Diluted) | 0.97 | 0.84 | 0.66 | 2.96 | 2.99 | 2.94 | 2.80 | 2.72 | 2.72 | 2.89 | 3 | 2.95 | 2.96 | 2.64 | 2.60 | 2.88 | 2.81 | 2.80 | 2.77 | 2.66 | 2.60 |
EBITDA | 1.81B | 1.77B | 1.66B | 2.36B | 2.34B | 2.29B | 2.19B | 2.15B | 2.12B | 2.12B | 2.1B | 2.07B | 2.09B | 2.07B | 2.09B | 2.18B | 2.16B | 2.15B | 2.11B | 2.06B | 2.01B |
EBIT | 632M | 603M | 590.6M | 1.31B | 1.3B | 1.26B | 1.18B | 1.14B | 1.12B | 1.14B | 1.17B | 1.16B | 1.2B | 1.19B | 1.22B | 1.33B | 1.32B | 1.33B | 1.3B | 1.28B | 1.26B |
Depreciation & Amortization | 1.18B | 1.17B | 1.07B | 1.05B | 1.04B | 1.03B | 1.01B | 1.01B | 992.4M | 983M | 922.43M | 911.23M | 893.53M | 876.93M | 870.55M | 853.55M | 840.55M | 825.15M | 813.63M | 784.03M | 753.63M |
Add to Watchlist
Select watchlists to add or remove EMLAF